Uncategorized
CDC investigates fungal endophthalmitis cases
The Centers for Disease Control and Prevention (CDC) will investigate cases of fungal endophthalmitis
that appear to be unrelated to those associated with a Florida company that led to last month's FDA recall of
Brilliant Blue G (see Ophthalmology Times eReport, March 28, 2012).